E. D. Schastnyy

ORCID: 0000-0003-2148-297X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Healthcare Systems and Public Health
  • Bipolar Disorder and Treatment
  • Cardiac Health and Mental Health
  • Human Health and Disease
  • Mental Health Treatment and Access
  • Long-Term Effects of COVID-19
  • Treatment of Major Depression
  • Electroconvulsive Therapy Studies
  • COVID-19 and Mental Health
  • Tryptophan and brain disorders
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Neurological Disorders and Treatments
  • Schizophrenia research and treatment
  • Mental Health Research Topics
  • Advanced Neuroimaging Techniques and Applications
  • Alcoholism and Thiamine Deficiency
  • Health, psychology, and well-being
  • Intensive Care Unit Cognitive Disorders
  • Health and Well-being Studies
  • Cancer survivorship and care
  • Monoclonal and Polyclonal Antibodies Research
  • Psychological and Temporal Perspectives Research
  • Heart Rate Variability and Autonomic Control
  • Mental Health and Psychiatry
  • Suicide and Self-Harm Studies

Tomsk National Research Medical Center
2017-2025

Russian Academy of Sciences
2020-2025

Mental Health Research Institute
2012-2025

Siberian State Medical University
2024

Research Medical Center
2018

Mental Health Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
2007-2013

Aim . To study the presence and severity of insomnia in patients with comorbid coronary heart disease (CHD) depressive disorder (DD). Materials methods The included 132 CHD (class II–III exertional angina after myocardial infarction experienced more than 6 months ago): 58 DD 74 without depression. Beck Depression Inventory (BDI) was used to diagnose DD. diagnosis all cases confirmed by a therapist. Sleep disturbances were assessed using Sheehan Patient-Rated Anxiety Scale (ShAS). data...

10.20538/1682-0363-2024-4-105-110 article EN cc-by Bulletin of Siberian Medicine 2025-01-24

To assess the influence of comorbid affective disorders (AD) on clinical and dynamic indicators alcohol dependence syndrome (ADS), level aggression in patients, to examine gender differences. Two groups were analyzed: Group F10 (n = 149) included patients with ADS without AD, group + F3 61) AD. Clinical-psychopathological, clinical-follow-up, psychometric, statistical methods used. Comorbidity AD reduces differences duration lucid periods, depressogenic effects alcohol, levels physical...

10.1080/15332640.2025.2468835 article EN Journal of Ethnicity in Substance Abuse 2025-03-08

Background: Depression and cognitive impairment are recognized complications of COVID-19. This study aimed to assess performance in clinically diagnosed post-COVID depression (PCD, n = 25) patients using neuropsychological testing. Methods: The involved 71 with matched control groups: recovered COVID-19 individuals without (n 18) prior history 19). A group was identified based on psychiatric diagnosis, a comparison (noPCD, 46) included participants neurological complications, excluding...

10.3390/jcm13051442 article EN Journal of Clinical Medicine 2024-03-01

The aim was to study the clinical-psychopathological, clinical-follow-up, clinical-dynamic features of mood disorders (MD) and alcohol use disorder (AUD) with their comorbidity combinations. Materials methods . included 88 people AUD MD: 33 women (37.5%) 55 (62.5%) men. first group 31 patients (35,0%) without comorbid affective symptoms, second 29 (33.0%) MD dependence, third 28 (32.0%) MD. There were no statistically significant differences between groups by age sex composition, level...

10.20538/1682-0363-2019-4-110-118 article EN cc-by Bulletin of Siberian Medicine 2020-01-14

Background: numerous studies indicate a high level of comorbidity bipolar disorder with other psychiatric disorders. Alcohol dependence is one the most common comorbid pathologies, along anxiety disorders and personality Objective: determination frequency BAR alcohol in patients specialized hospital identiашcation clinical dynamic features this comorbidity. Patients methods: unit, 188 diagnosed according to ICD-10 (136 women 52 men) were examined. The age female was 41.6 ± 14.4 years, male —...

10.30629/2618-6667-2023-21-6-42-49 article EN cc-by Psikhiatriya 2024-01-03

Background: Depression is one of the most severe sequelae COVID-19, with major depressive disorder often characterized by disruption in white matter (WM) connectivity stemming from changes brain myelination. This study aimed to quantitatively assess myelination clinically diagnosed post-COVID depression (PCD) using recently proposed MRI method, macromolecular proton fraction (MPF) mapping. Methods: The involved 63 recovered COVID-19 patients (52 mild, 11 moderate, and 2 severe) at 13.5 ±...

10.3390/jcm13164692 article EN Journal of Clinical Medicine 2024-08-09

Depression is one of the most severe sequelae COVID-19, with major depressive disorder often characterized by disruption in white matter (WM) connectivity , stemming from changes brain myelination. This study aimed to quantitatively assess myelination clinically diagnosed post-COVID depression using recently proposed MRI method, macromolecular proton fraction (MPF) mapping. The involved 63 recovered COVID-19 patients (52 mild, 11 moderate, 2 severe) at 13.5±10.0 months post-recovery, matched...

10.20944/preprints202312.0698.v1 preprint EN 2023-12-11

Objective: to identify the structure and clinical features of affective disorders (AD) efficiency antidepressants in in-patients with chronic coronary artery disease (ChCAD), living Tomsk Region. Materials м ethods. At a heart center, 1,131 patients ChCAD were examined: 290 persons (25.6%) AD revealed, among them 72.1% men ( n = 209) 27.9% women 81). Mean age was (63.5 ± 9.4) years (57.9 7.2) р 0.004). structure, main syndromes, severity depression anxiety according data self-questionnaires...

10.20538/1682-0363-2018-4-85-93 article EN cc-by Bulletin of Siberian Medicine 2018-12-24

The aim of the study was to reveal clinical and dynamic characteristics affective disorders (AD) in comorbidity with alcohol addiction (AA). Materials methods. 65 patients [22 women (34%) 43 men (66%)] were examined. main group included 34 aged 44.5 [36.0; 51.5] comorbid comparison 31 45 years [32; 52] without narcological pathology. Compared groups matched by sex, age nosological structure (p > 0.05). following methods used study: psychopathological, follow-up, psychometric, statistical,...

10.20538/1682-0363-2020-1-29-35 article EN cc-by Bulletin of Siberian Medicine 2020-04-16

Objective: to study cognitive functions and level of proteins acute brain damage in a group patients receiving Cerebrolysin, comparison the pre- postoperative period coronary artery bypass graft surgery. Materials methods. The open-label randomized comparative controlled parallel included 60 men. average age therapy with Cerebrolysin was 61.5 (57÷66) years, – 61 (56÷65) years ( р > 0.05) group. Results. Groups differed statistically significantly according left ventricular ejection...

10.20538/1682-0363-2018-4-72-84 article EN cc-by Bulletin of Siberian Medicine 2018-12-24

The aim was to study the impact of late diagnostics bipolar disorder (BD) on main clinical and dynamic indicators, suicidal behavior, subjective evaluation social adaptation level, employment status patients. Patients methods: 121 in-patients (38 males, 31.4% 83 females, 68.6%) with a veried diagnosis (according ICD-10 criteria) were examined. A comparative indicators that could reect causes consequences delayed performed. rst group ( n = 46) included patients BD during initial visit...

10.30629/2618-6667-2022-20-2-24-31 article EN cc-by Psikhiatriya 2022-07-04

Objective : to study clinical-biological features of affective disorders including their comorbidity with coronary artery disease and personality efficacy psychopharmacotherapy in these patients. Material Methods . In the first group at a heart station 290 patients chronic (209 men 81 women) were fully examined. The second included 120 (40 80 psychiatric hospital disorder comorbid disorders. third 29 depressive control (n=21). Results Data on significant clinical-dynamic, biological...

10.29001/2073-8552-2018-33-3-86-92 article EN cc-by The Siberian Journal of Clinical and Experimental Medicine 2018-11-28

Objective : to study the incidence rate of personality and anxiety disorders their interrelationship in seniors medical university. Materials methods . The screening for detection using Generalized Anxiety Disorder-7 (GAD-7) Standardized Assessment Personality – Abbreviated Scale (SAPAS) scales included 104 senior-year students In studied sample, males (n = 46; 44.2%) females 58; 55.8%) (p < 0.05) were equally represented, average age men was 23 (23; 25) years, women 23) years....

10.20538/1682-0363-2019-4-143-149 article EN cc-by Bulletin of Siberian Medicine 2020-01-14

Failure to diagnose bipolar disorder (BD) in time leads an increase suicide risk, worse prognosis of the disease, and socioeconomic burden. Aim : assess incidence comorbidity other mental behavioral disorders, as well sequence formation this multimorbidity. Patients methods Affective States Department Mental Health Research Institute TNRMC, 121 patients with a diagnosis were selected for study group according ICD-10 diagnostic criteria. The predominance women was revealed (n = 83; 68.6%; p...

10.30629/2618-6667-2021-19-3-15-21 article EN cc-by Psikhiatriya 2021-10-14

Introduction Mood disorders in the elderly are a relevant clinical problem associated with high prevalence and frequent co-morbidity chronic somatic diseases. Objective Study of traits depression elder persons disorders. Methods The investigation was entered by 582 (women = 391 (67,1%), men 191 (32,9%)), mean age women has constituted 67,5 ± 5,8 years, - 62,1 3,8 years. Criteria inclusion Age 55 years higher, 60 level according to Beck Inventory more than 22 scores. Results Affective were...

10.1016/s0924-9338(11)72560-3 article EN European Psychiatry 2011-03-01

Depression and cognitive impairment are recognized complications of COVID-19. This study aimed to assess performance in clinically diagnosed post-COVID depression (PCD) patients using neuropsychological testing. The involved 71 patients, with matched control groups: recovered COVID-19 individuals without (n=18) prior history (n=19). A group (PCD, n=25) was identified based on psychiatric diagnosis, a comparison (noPCD, n=46) included participants neurological complications, excluding...

10.20944/preprints202312.0937.v1 preprint EN 2023-12-13

BACKGROUND: The development of new drugs to improve the effectiveness treatment and rehabilitation programs for patients suffering from addiction diseases, which are non-addictive have a stimulating effect on detoxification processes in body, can increase therapy reduce cost treatment. A deficiency GABAergic inhibition brain structures plays leading role occurrence paroxysmalness. innovative anticonvulsant Galodif® (1-[(3-chlorophenyl)(phenyl)methyl]urea), GABAA receptor modulator, has low...

10.17816/rcf607434 article EN Reviews on Clinical Pharmacology and Drug Therapy 2024-02-01

Introduction. Currently, the study of comorbidity, which is characteristic clinical picture modern patients, relevant. This also applies to psychiatric disorders in cardiovascular diseases, are common, affect social functioning and determine biological characteristics patients prognosis. Bipolar disorder coronary heart disease one example such a comorbidity. Recent evidence suggests that up 40% with bipolar die from disease. Aim: To frequency their dynamic features chronic artery assessment...

10.29001/2073-8552-2024-39-3-64-71 article EN Siberian Journal of Clinical and Experimental Medicine 2024-10-01

The contribution of comorbid with coronary artery disease (CAD) mood disorders (MD) into total mortality is contradictory. Objective To study frequency and time until death due to general causes in groups patients MD, without them as well interrelationship these indicators MD therapy antidepressants. Methods Inpatients chronic CAD ( n = 333) under conservative were investigated (31% females 103), 69% males 230), mean age 61.8 ± 9.8 years). Team cardiologists psychiatrists followed up for 7...

10.1016/j.eurpsy.2017.01.554 article EN European Psychiatry 2017-04-01

Introduction . Currently, clinical trials (CT) remain the only technology, which provides proof of efficacy and safety new drugs their subsequent release to market. Medical researcher informed consent (IC) are main (and often only) source information for patient about upcoming trials, thus have a direct impact on perception patient’s decision participation. However, degree influence these factors participants still remains unclear. Materials methods. A multicenter cross-sectional study was...

10.20538/1682-0363-2016-4-40-51 article EN cc-by Bulletin of Siberian Medicine 2016-01-01

Aim. To determine gender differences in self-reported social functioning of patients with comorbidity affective disorders (ADs) and chronic coronary artery disease. Materials methods . Self-reported 248 cardiological (194 men (78.2%) 54 women (21.8%)) disease (CAD) ADs was studied using the Social Adaptation Self-evaluation Scale (SASS). The mean age CAD (57.2 ± 6.5) years, (59.3 7.1), p = 0.04. Qualitative quantitative indicators were investigated Mann – Whitney, Wilcoxon T-test; χ2...

10.20538/1682-0363-2021-1-75-82 article EN cc-by Bulletin of Siberian Medicine 2021-04-12

Study of influence depression on assessment cardiovascular risk in IHD patients with components metabolic syndrome (MS). Among 376 (59,1±10,3 years) 72,9% had AH, 40,2% DM type 2 or disturbance tolerance to glucose (DTG), 45,9% obesity, 42,2% dyslipidemia (DLP). Methods investigation were as follows: clinicalpsychopathological, experimental-psychological, HADS, MADRS. Depressive disorders have been diagnosed 109 (29%) cardiologic institution. 79,8% affective disorders, 20,2% mixed...

10.1016/s0924-9338(13)76962-1 article EN European Psychiatry 2013-01-01
Coming Soon ...